Healthcare Services

An Important Factor Driving the Convalescent Plasma Therapy Market Is the Rising Prevalence Of Infectious Diseases Driving The Market Growth Due To Increased Infections

March 31, 2026March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Convalescent Plasma Therapy Market Expected To Change Between 2026 And 2030?

The convalescent plasma therapy market size has seen swift expansion in recent years. It is anticipated to expand from $0.06 billion in 2025 to $0.06 billion in 2026, at a compound annual growth rate (CAGR) of 13.6%. Historically, this growth can be attributed to the urgent demand for pandemic treatment, the absence of specific targeted therapeutics, the availability of recovered donors, emergency use authorizations, and hospital-based plasma transfusion procedures.

The convalescent plasma therapy market is poised for significant expansion in the coming years. It is projected to reach $0.11 billion by 2030, driven by a robust compound annual growth rate (CAGR) of 13.5%. This growth throughout the forecast period is attributed to several factors, including enhanced preparedness for future outbreaks, advancements in antibody testing, superior plasma storage technologies, the broadening of transfusion services, and intensified research into immune therapies. Furthermore, prominent trends during this period are expected to feature increased adoption in treating emerging infectious diseases, a sharpened focus on high-titer antibody plasma, the development of plasma collection infrastructure, more refined donor screening and selection, and its integration into hospital-based critical care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp

What Drivers Are Expected To Influence The Convalescent Plasma Therapy Market During The Forecast Period?

The escalating occurrence of infectious diseases is projected to drive expansion within the Convalescent Plasma Therapy market. These diseases, stemming from detrimental microorganisms like bacteria, viruses, fungi, or parasites, are transmissible among individuals or through tainted surroundings. A surge in urbanization and international travel contributes to this heightened prevalence, fostering closer human interactions and accelerating pathogen dissemination. Convalescent plasma therapy aids in combating these conditions by utilizing plasma from individuals who have recovered, which holds antibodies capable of neutralizing pathogens and bestowing passive immunity upon those currently afflicted, thus bolstering the body’s defense mechanisms. For example, the World Health Organization (WHO), a Switzerland-based intergovernmental body, reported in October 2024 that new tuberculosis diagnoses reached around 8.2 million people in 2023, an increase from 7.5 million in 2022, marking the highest figure since global TB surveillance commenced. Consequently, the increasing prevalence of infectious diseases is propelling the growth of the Convalescent Plasma Therapy market.

Convalescent Plasma Therapy Market Driver: Increase In The Number Of Hospitals Is Fueling The Growth Of The Convalescent Plasma Therapy Market

The expansion in the count of hospitals is anticipated to stimulate the advancement of the Convalescent Plasma Therapy market in the future. Hospitals function as specialized medical institutions offering a broad spectrum of healthcare provisions, encompassing diagnosis, therapy, and patient care for diverse medical ailments. A higher number of hospitals frequently aligns with enhanced healthcare infrastructure, which subsequently leads to superior capabilities for gathering, preparing, and dispensing convalescent plasma, thereby elevating the standard of treatment. For example, data from the Hellenic Statistical Authority, a national government statistics body based in Greece, indicated in April 2025 that the nation’s hospital count grew from 265 units in 2022 to 266 units in 2023, signifying a 0.4% uptick. Consequently, the growing number of hospitals is driving the growth of the Convalescent Plasma Therapy market.

How Is The Convalescent Plasma Therapy Market Structured Across Different Segments?

The convalescent plasma therapy market covered in this report is segmented –

1) By Antibody type: IgM, IgG, IgA

2) By Application: Prophylaxis, Treatment

3) By End-Users: Hospitals And Clinics, Laboratories And Research institutes

Subsegments:

1) By IgM: Early-Stage Infection Plasma, Acute Phase Plasma

2) By IgG: High Titer IgG Plasma, Standard IgG Plasma

3) By IgA: Plasma Rich In IgA, Specific IgA Antibody Plasma

What Major Market Trends Are Driving Changes In The Convalescent Plasma Therapy Market?

Leading companies in the convalescent plasma therapy market are concentrating on developing innovative solutions, such as hyperimmune globulin therapies, to improve treatment efficacy and address challenges associated with standard plasma treatments. Hyperimmune Globulin Therapies are defined as treatments that utilize plasma with a high concentration of specific antibodies, sourced from individuals who have recovered from an infection, to provide targeted and potent immune support for patients. For instance, in October 2023, Kamada Ltd., an Israel-based biopharmaceutical company, announced significant advancements regarding its product CYTOGAM (Cytomegalovirus Immune Globulin Intravenous [Human]), which is now commercially available in the U.S. following FDA approval for its manufacturing facility in Israel. At IDWeek 2023, new clinical data demonstrated a five-year survival benefit for high-risk CMV mismatch lung transplant patients receiving CYTOGAM. Additionally, Kamada has established its first Scientific Advisory Board to enhance U.S. clinical programs for the product.

Which Major Players Dominate The Convalescent Plasma Therapy Market?

Major companies operating in the convalescent plasma therapy market are Bio Farma, Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America’s Blood Centers, Blood Centers of America Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank, Kedrion Biopharma Inc.

Read the full convalescent plasma therapy market report here:

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Which Region Is Forecast To Lead The Convalescent Plasma Therapy Market In Terms Of Market Size?

North America was the largest region in the convalescent plasma therapy market in 2025. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Convalescent Plasma Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3233&type=smp

Browse Through More Reports Similar to the Global Convalescent Plasma Therapy Market 2026, By The Business Research Company

Contrast Media Injectors Global Market Report

https://www.thebusinessresearchcompany.com/report/contrast-media-injectors-global-market-report

Medical Imaging Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-imaging-equipment-global-market-report

Interventional Neurology Devices And Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/interventional-neurology-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795